Transfer from insulin to sulfonylurea treatment in a chinese patient with permanent neonatal diabetes mellitus due to a KCNJ11 R201H mutation.
Xiao
X
X
Key Laboratory of Endocrinology, Ministry of Health, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. xiaoxinhua@medmail.com.cn
Wang
T
T
Li
W
W
Song
H
H
Gong
C
C
Diao
C
C
Yu
M
M
Yuan
T
T
Zhang
Y
Y
Sun
X
X
Zhang
Q
Q
Lu
K
K
Wang
H
H
Schmitz
O
O
Hansen
T
T
D044466:Asian People / Q000235:genetics; D001483:Base Sequence; D002675:Child, Preschool; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D008969:Molecular Sequence Data; D020125:Mutation, Missense; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D000099161:Kcnj11 Channel
D007004:Hypoglycemic Agents; D007328:Insulin; D024661:Potassium Channels, Inwardly Rectifying; D013453:Sulfonylurea Compounds; D000099161:Kcnj11 Channel